New cell therapy aims to rebuild immunity after transplant for young cancer patients
Disease control
Recruiting now
This early-phase study tests a cell therapy called T-allo10 given after a special stem cell transplant in children and young adults with blood cancers. The goal is to see if it safely helps rebuild the immune system faster without causing severe graft-versus-host disease. About 2…
Phase: PHASE1 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated May 17, 2026 06:22 UTC